C T DANG LIMITEDActive

Company number 08764117Private limited companyIncorporated 2013

Key figures

−£76,712-129.6%
Net assets 2024/25
-150 k-100 k-50 k02019/202020/212021/222022/232023/242024/25

Like most small UK companies, C T DANG LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand186,974128,04194,33091,71266,035
Total assets1,734,3831,538,1781,364,0871,170,226997,641
Total liabilities1,778,9971,638,4311,397,2751,190,1641,064,378
Net assets / total equity-68,209-117,684-46,997-33,409-76,712
Average number of employees1311111213

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

community pharmacy

As described in the company's latest filed accounts.

Summary: C T DANG LIMITED

Company

C T DANG LIMITED is a private limited company registered with Companies House under company number 08764117. It was incorporated on 6 Nov 2013. Its status is active. The registered office is in London (W1T). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Nov 2025); the company files small company accounts (filleted). Net assets were −£76,712, down 129.6% on the previous year. Cash at bank and in hand was £66,035. Total assets were £997,641 and total liabilities £1,064,378. The company had an average of 13 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Aug 2027. The next confirmation statement is due by 7 Jan 2027.